Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

H

Hvidovre University Hospital

Other

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

84

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Pulmonary Immune Cell-microbiome Interactions in Acute Respiratory Distress Syndrome: The ILLUMINA-1 Study

Pulmonary Immune Cell-microbiome Interactions in the Healthy Lung: The ILLUMINA-2 Study

Earlier

Sep 23, 2026TrialDoes Surgery-Induced Trauma Influence Postoperative Safety and Outcome Comparing Total vs. Medial Unicompartmental Knee Arthroplasty (SITA): A Prospective Cohort Study

Sep 22, 2026TrialPhysical Activity as Prevention of Hospital-Associated Disability in Acutely Hospitalized Older Adults - How Much is Enough and What do the Patients Prefer?

Sep 19, 2026TrialThe Right Treatment for the Right Patient at the Right Time - A Prospective Cohort Study of 5,000 Patients With Knee Osteoarthritis

Sep 19, 2026TrialNutritional Status in Adults With Diabetic Foot in an Outpatient Wound Clinic: A Feasibility and Pilot Study

Sep 19, 2026TrialStrengthening First-time Fathers' Engagement in Early Parenthood When Having a Preterm Infant - The SUPPORTED Study.

Sep 10, 2026TrialAutomated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD

4 more events

Aug 19, 2026TrialFeasibility, Fidelity, and Acceptability of a Co-designed Intervention to Promote Mobility in Patients After Hip Fracture Surgery

May 2, 2024TrialMetabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery

Mar 18, 2023TrialFeasibility Study of Using Fecal Microbiota Transplants in Anorexia Nervosa

Jun 1, 2022TrialPeriostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)